5C h is a r i F V ,Is o g a w a M ,W ie la n d S F . P a th o g e n e s is o f h e p a titis Bv ir u s in fe c tio n . P a th o l B io l( P a r is ) , 2 0 1 0 ,5 8 : 2 5 8 -2 6 6 .
8C u i. A r t if ic ia l liv e r c u r a tiv e e ffe c t o b s e rv a tio n o f p la s m a e x c h a n g ein th e t r e a tm e n t o f s e vere h e p a titis . J o u r n a l o f m e d ic a l a n d h e a lthc a r e,2 0 1 4,2 2 : 2 1.
5LEE JY, KIM SB, CHANG JW, et al. Comparison of the molecular adsorbent recirculating system and plasmapheresis for patients with graft dysfunction after liver transplantation [C]. Transplant Proc, 2010, 42(7) : 2625 -2630.
6YAMAMOTO R, NAGASAWA Y, MARUBASHI S, et al. Ear- ly plasma exchange for progressive liver failure in recipients of adult - to - adult living - related liver transplants[ J ]. Blood Purif, 2009, 28(1): 40-46.
7ZHANG XQ, JIANG L, YOU JP, et al. Efficacy of short - term dexamethasone therapy in acute -on -chronic pre - liver failure[J]. Hepatol Res, 2011, 41(1) : 46 -53.
8OPPERT M, RADEMACHER S, PETRASCH K, et al. Extra- corporeal liver support therapy with Prometheus in patients with liver failure in the intensive care unit[J]. Ther Apher Di- al, 2009, 13(5) : 426 -430.
9XU X, LIU X, LING Q, et al. Artificial liver support system combined with liver transplantation in the treatment of pa- tients with acute - on - chronic liver failure [ J ]. PLoS One, 2013, 8 ( 3 ) : e58738.
